|
OXSR1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.416000E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.650500E-02 |
| Normal-vs-Stage2 |
1.536240E-01 |
| Normal-vs-Stage3 |
1.869820E-01 |
| Normal-vs-Stage4 |
3.436400E-02 |
| Stage1-vs-Stage2 |
7.400600E-01 |
| Stage1-vs-Stage3 |
8.507200E-01 |
| Stage1-vs-Stage4 |
3.334600E-01 |
| Stage2-vs-Stage3 |
8.998800E-01 |
| Stage2-vs-Stage4 |
5.161000E-01 |
| Stage3-vs-Stage4 |
4.784600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.381500E-02 |
| Normal-vs-AfricanAmerican |
1.776110E-02 |
| Normal-vs-Asian |
2.302400E-02 |
| Caucasian-vs-AfricanAmerican |
3.063200E-01 |
| Caucasian-vs-Asian |
4.456800E-01 |
| AfricanAmerican-vs-Asian |
6.460400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.880200E-03 |
| Normal-vs-Female |
7.249200E-01 |
| Male-vs-Female |
8.456400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.349860E-02 |
| Normal-vs-Extreme_Weight |
5.256700E-03 |
| Normal-vs-Obese |
3.805400E-01 |
| Normal-vs-Extreme_Obese |
9.807200E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.467000E-01 |
| Normal_Weight-vs-Obese |
2.289200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.107600E-01 |
| Extreme_Weight-vs-Obese |
1.829770E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.329400E-01 |
| Obese-vs-Extreme_Obese |
6.850600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.847400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.123800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.232320E-02 |
| Normal-vs-Age(81-100Yrs) |
1.740480E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.523200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.700000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.707820E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.260800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.358800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.128000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.301000E-01 |
| Normal-VS-Type2 PRCC |
1.695210E-03 |
| Normal-VS-KIRP CIMP |
1.153650E-01 |
| Normal-VS-Unclassified PRCC |
2.983000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.263710E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.272100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.097000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.116900E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.607600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.741800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.77429999999035E-05 |
| Normal-vs-N1 |
1.174580E-01 |
| Normal-vs-N2 |
4.287000E-01 |
| N0-vs-N1 |
1.896190E-01 |
| N0-vs-N2 |
7.461800E-01 |
| N1-vs-N2 |
7.906000E-01 |
|
|
